Joachim-Friedrich Kapp

SVP, Clinical Development, Autoimmunity at Aditx Therapeutics

Brings over 3 decades of experience with regulatory agencies such as the FDA and its European counterparts. Board-certified in Pharmacology & Toxicology, and Clinical Pharmacology. Former President Global Business Unit (GBU) Specialized Therapeutics at Schering AG.

Location

Berlin, Germany

Links


Org chart


Teams


Offices

This person is not in any offices


Aditx Therapeutics

Aditx Therapeutics, Inc. (Aditxt™) is a biotech innovation company with a mission of prolonging life and enhancing its quality by improving the health of the immune system.


Industries

Employees

11-50

Links